Antibiotic resistance of Helicobacter pylori:: a cross-sectional study in consecutive patients, and relation to ethnicity

被引:15
作者
Loffeld, RJLF [1 ]
Fijen, CAPMJ [1 ]
机构
[1] De Heel Zaans Med Ctr, Dept Internal Med & Microbiol, NL-1500 EE Zaandam, Netherlands
关键词
H; pylori; antibiotic resistance; metronidazole; clarithromycin; ANTIMICROBIAL SUSCEPTIBILITY; METRONIDAZOLE RESISTANCE; UNITED-STATES; PREVALENCE; CLARITHROMYCIN; ERADICATION; MULTICENTER; STRAINS; DISEASE; ULCER;
D O I
10.1046/j.1469-0691.2003.00553.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives To assess primary antibiotic resistance in a given population and relate the results to ethnicity. Materials and methods Consecutive cultures were tested for antibiotic susceptibility with the Etest. Three populations were studied separately: ethnic Dutch people, patients of Turkish descent, and patients originating from Africa and the Middle East. Results Over a period of 5.5 years, 976 (32%) biopsy specimens from 3010 patients were positive for Helicobacter pylori . Metronidazole and clarithromycin resistance were present in 25.8% and 4.8% of the strains, respectively. The number of metronidazole-resistant strains showed a gradual decrease, while clarithromycin resistance showed a slight increase during the study period. Antimicrobial resistance in patients of Turkish descent and in those originating from Africa or the Middle East was significantly higher than in ethnic Dutch people, 35% and 9.1% versus 21% and 2.9%, respectively (P = 0.003 and P = 0.002). Conclusion It is important to take ethnicity into account when studying antibiotic resistance. The numbers of metronidazole- and clarithromycin-resistant strains can vary considerably between people of different ethnic origin living in the same region.
引用
收藏
页码:600 / 604
页数:5
相关论文
共 18 条
[1]   HIGH PREVALENCE OF HELICOBACTER-PYLORI METRONIDAZOLE RESISTANCE IN MIGRANTS TO EAST LONDON - RELATION WITH PREVIOUS NITROIMIDAZOLE EXPOSURE AND GASTRODUODENAL DISEASE [J].
BANATVALA, N ;
DAVIES, GR ;
ABDI, Y ;
CLEMENTS, L ;
RAMPTON, DS ;
HARDIE, JM ;
FELDMAN, RA .
GUT, 1994, 35 (11) :1562-1566
[2]  
CAYLA R, 1993, ACTA GASTROENTEROL S, V56, P65
[3]   EVALUATION OF A NEW SELECTIVE MEDIUM FOR CAMPYLOBACTER-PYLORI [J].
DENT, JC ;
MCNULTY, CAM .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (04) :555-558
[4]  
Fedorak R, 1997, GASTROENTEROLOGY, V112, pA115
[5]  
GLUPCZYNSKI Y, 1992, EUR J CLIN MICROBIOL, V11, P777
[6]   Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: Importance of medium, inoculum, and incubation time [J].
Hartzen, SH ;
Andersen, LP ;
Bremmelgaard, A ;
Colding, H ;
Arpi, M ;
Kristiansen, J ;
Justesen, T ;
Espersen, F ;
FrimodtMoller, N ;
Bonnevie, O .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (12) :2634-2639
[7]  
Houben MHMG, 1999, ALIMENT PHARM THER, V13, P1047
[8]   Guidelines for the management of Helicobacter pylori infection [J].
Howden, CW ;
Hunt, RH .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (12) :2330-2338
[9]   Prevalence of antimicrobial resistance in eighty clinical isolates of Helicobacter pylori [J].
Iovene, MR ;
Romano, M ;
Pilloni, AP ;
Giordano, B ;
Montella, F ;
Caliendo, S ;
Tufano, MA .
CHEMOTHERAPY, 1999, 45 (01) :8-14
[10]   The MACH2 study:: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies [J].
Lind, T ;
Mégraud, F ;
Unge, P ;
Bayerdörffer, E ;
O'Morain, C ;
Spiller, R ;
van Zanten, SV ;
Bardhan, KD ;
Hellblom, M ;
Wrangstadh, M ;
Zeijlon, L ;
Cederberg, C .
GASTROENTEROLOGY, 1999, 116 (02) :248-253